MetaADEDB 2.0 @ LMMD
Silymarin
(SEBFKMXJBCUCAI-HKTJVKLFSA-N)
Structure
SMILES
OC[C@H]1Oc2ccc(cc2O[C@@H]1c1ccc(c(c1)OC)O)[C@H]1Oc2cc(O)cc(c2C(=O)[C@@H]1O)O
Type(s)
Experimental; Investigational
Molecular Formula:
C25H22O10
Molecular Weight:
482.436
Log P:
2.3627
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
5
TPSA:
155.14
CAS Number(s):
22888-70-6; 36804-17-8; 802918-57-6
Synonym(s)
1.
Silymarin
2.
Carsil
3.
Karsil
4.
Legalon
5.
Silimarin
External Link(s)
MeSHD012838
PubChem Compound31553
BindingDB50084982
ChEBI9144
CHEMBLCHEMBL431701
DrugBankDB09298
KEGGdr:D08515
ZINC2033589
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acute kidney injury10454517CTD
2Alanine Aminotransferase IncreasedOFFSIDES
3AnhidrosisOFFSIDES
4AnosmiaOFFSIDES
5Application site necrosisOFFSIDES
6AscitesOFFSIDES
7AsterixisOFFSIDES
8Blood alkaline phosphatase increasedOFFSIDES
9Blood amylase decreasedOFFSIDES
10Blood chloride decreasedOFFSIDES
11Blood iron increasedOFFSIDES
12Blood potassium decreasedOFFSIDES
13Blood sodiumOFFSIDES
14Blood thyroid stimulating hormone increasedOFFSIDES
15Blood urea increasedOFFSIDES
16Brain ContusionOFFSIDES
17Cardiotoxicity24062023
26335259
CTD
18Chemical and Drug Induced Liver Injury

View details

CTD
19CholangiolitisOFFSIDES
20DiplopiaOFFSIDES
21DrowsinessOFFSIDES
22Dyslipidemias24062023CTD
23Edema10753220
28422384
CTD
24Endometrial HyperplasiaOFFSIDES
25EpistaxisOFFSIDES
26ErythemaOFFSIDES
27Escherichia coli Infections28454924CTD
28Escherichia sepsisOFFSIDES
29Failure of implantOFFSIDES
30Fatty Liver, Alcoholic27795452CTD
31Fatty Liver23348005
25410024
CTD
32Febrile NeutropeniaOFFSIDES
33Food PoisoningOFFSIDES
34Gamma-glutamyltransferase abnormalOFFSIDES
35GranulomaOFFSIDES
36Heart Diseases18487002CTD
37Hemorrhage20144634CTD
38HepatitisOFFSIDES
39Hepatomegaly

View details

CTD
40Hyperglycemia22137898
29753610
CTD
41Hypotension26335259CTD
42IncontinenceOFFSIDES
43Inflammation17213517
25410024
28422384
CTD
44Insulin Resistance23348005CTD
45Intracranial AneurysmOFFSIDES
46Kidney Diseases

View details

CTD
47Liver Cirrhosis, Experimental

View details

CTD
48Liver Cirrhosis

View details

CTD
49Liver diseases17213517CTD
50Liver neoplasms19168119CTD
51Lung Neoplasms16788158CTD
52Lymphocyte percentage decreasedOFFSIDES
53Manganese Poisoning22033861CTD
54Massive Hepatic Necrosis28454924CTD
55Multiple SclerosisOFFSIDES
56Mushroom Poisoning17213517CTD
57Necrosis

View details

CTD
58Neoplasm Invasiveness25868784CTD
59Nerve Degeneration20964710CTD
60Non-alcoholic Fatty Liver Disease28454924
30713255
CTD
61Obesity30713255CTD
62Open woundOFFSIDES
63PancreatitisOFFSIDES
64Parkinsonian Disorders23963992CTD
65Prostatic Hyperplasia23500659CTD
66Prostatic Neoplasms16000596CTD
67Prothrombin time abnormalOFFSIDES
68QuadriparesisOFFSIDES
69Septic ShockOFFSIDES
70Skin Neoplasms10753220CTD
71StressOFFSIDES
72Supraventricular tachycardiaOFFSIDES
73TinnitusOFFSIDES
74Transfusion ReactionOFFSIDES
75Uterine PolypOFFSIDES
76Varicocele23659554CTD
77Ventricular Dysfunction, Left26335259CTD
78Vulvovaginal pruritusOFFSIDES
79Weight Gain22354081
31175915
CTD
80leukemia20932957CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.